|
|||||
      |
A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, chemistry, Europe, licensing, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, FDA, investment, licensing, life sciences, mathematics, medical device, physical sciences, physics, robotics, university, venture capital 
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases 
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, cancer, chemistry, Japan, licensing, life sciences, pharmaceuticals, physical sciences, university 
A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors. . . . → Read More: Venture Investor to Back Semiconductor Start-Ups 
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal Comments are closed Intellectual property, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, licensing, life sciences, pharmaceuticals, physical sciences 
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe Comments are closed Intellectual property, New products, Regulations biomedical, economics, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals 
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins Comments are closed New products Australia, biomedical, biotechnology, chemistry, clinical trials, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, physical sciences, university 
A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems. . . . → Read More: Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals 
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies Comments are closed Intellectual property biomedical, biotechnology, chemistry, Europe, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts